239 related articles for article (PubMed ID: 24179173)
1. Systems biology analysis of Drosophila in vivo screen data elucidates core networks for DNA damage repair in SCA1.
Barclay SS; Tamura T; Ito H; Fujita K; Tagawa K; Shimamura T; Katsuta A; Shiwaku H; Sone M; Imoto S; Miyano S; Okazawa H
Hum Mol Genet; 2014 Mar; 23(5):1345-64. PubMed ID: 24179173
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice.
Ito H; Fujita K; Tagawa K; Chen X; Homma H; Sasabe T; Shimizu J; Shimizu S; Tamura T; Muramatsu S; Okazawa H
EMBO Mol Med; 2015 Jan; 7(1):78-101. PubMed ID: 25510912
[TBL] [Abstract][Full Text] [Related]
3. RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repair.
Taniguchi JB; Kondo K; Fujita K; Chen X; Homma H; Sudo T; Mao Y; Watase K; Tanaka T; Tagawa K; Tamura T; Muramatsu SI; Okazawa H
Hum Mol Genet; 2016 Oct; 25(20):4432-4447. PubMed ID: 28173122
[TBL] [Abstract][Full Text] [Related]
4. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
Cummings CJ; Orr HT; Zoghbi HY
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
[TBL] [Abstract][Full Text] [Related]
5. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.
Crespo-Barreto J; Fryer JD; Shaw CA; Orr HT; Zoghbi HY
PLoS Genet; 2010 Jul; 6(7):e1001021. PubMed ID: 20628574
[TBL] [Abstract][Full Text] [Related]
6. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.
Ju H; Kokubu H; Lim J
Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589
[TBL] [Abstract][Full Text] [Related]
7. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
[TBL] [Abstract][Full Text] [Related]
8. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.
Orr HT
Prog Neurobiol; 2012 Dec; 99(3):179-85. PubMed ID: 22531670
[TBL] [Abstract][Full Text] [Related]
9. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1.
Park J; Al-Ramahi I; Tan Q; Mollema N; Diaz-Garcia JR; Gallego-Flores T; Lu HC; Lagalwar S; Duvick L; Kang H; Lee Y; Jafar-Nejad P; Sayegh LS; Richman R; Liu X; Gao Y; Shaw CA; Arthur JSC; Orr HT; Westbrook TF; Botas J; Zoghbi HY
Nature; 2013 Jun; 498(7454):325-331. PubMed ID: 23719381
[TBL] [Abstract][Full Text] [Related]
10. Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signaled to DNA damage by ataxia-telangiectasia mutated kinase.
Suart CE; Perez AM; Al-Ramahi I; Maiuri T; Botas J; Truant R
Hum Mol Genet; 2021 May; 30(8):706-715. PubMed ID: 33772540
[TBL] [Abstract][Full Text] [Related]
11. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model.
Gehrking KM; Andresen JM; Duvick L; Lough J; Zoghbi HY; Orr HT
Hum Mol Genet; 2011 Jun; 20(11):2204-12. PubMed ID: 21427130
[TBL] [Abstract][Full Text] [Related]
12. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
Zu T; Duvick LA; Kaytor MD; Berlinger MS; Zoghbi HY; Clark HB; Orr HT
J Neurosci; 2004 Oct; 24(40):8853-61. PubMed ID: 15470152
[TBL] [Abstract][Full Text] [Related]
13. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.
Watase K; Weeber EJ; Xu B; Antalffy B; Yuva-Paylor L; Hashimoto K; Kano M; Atkinson R; Sun Y; Armstrong DL; Sweatt JD; Orr HT; Paylor R; Zoghbi HY
Neuron; 2002 Jun; 34(6):905-19. PubMed ID: 12086639
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.
Lim J; Crespo-Barreto J; Jafar-Nejad P; Bowman AB; Richman R; Hill DE; Orr HT; Zoghbi HY
Nature; 2008 Apr; 452(7188):713-8. PubMed ID: 18337722
[TBL] [Abstract][Full Text] [Related]
15. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
[TBL] [Abstract][Full Text] [Related]
16. A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
Sánchez I; Piñol P; Corral-Juan M; Pandolfo M; Matilla-Dueñas A
Hum Mol Genet; 2013 Sep; 22(17):3425-37. PubMed ID: 23630944
[TBL] [Abstract][Full Text] [Related]
17. Hsp70/Hsc70 regulates the effect phosphorylation has on stabilizing ataxin-1.
Jorgensen ND; Andresen JM; Pitt JE; Swenson MA; Zoghbi HY; Orr HT
J Neurochem; 2007 Sep; 102(6):2040-2048. PubMed ID: 17540008
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.
Venkatraman A; Hu YS; Didonna A; Cvetanovic M; Krbanjevic A; Bilesimo P; Opal P
Hum Mol Genet; 2014 Jul; 23(14):3733-45. PubMed ID: 24594842
[TBL] [Abstract][Full Text] [Related]
19. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice.
Serra HG; Byam CE; Lande JD; Tousey SK; Zoghbi HY; Orr HT
Hum Mol Genet; 2004 Oct; 13(20):2535-43. PubMed ID: 15317756
[TBL] [Abstract][Full Text] [Related]
20. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
Watase K; Gatchel JR; Sun Y; Emamian E; Atkinson R; Richman R; Mizusawa H; Orr HT; Shaw C; Zoghbi HY
PLoS Med; 2007 May; 4(5):e182. PubMed ID: 17535104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
